ResearcherNankai UniversityNo recent work listed
Xiaodong Sun
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2011: 1 paper · 2012: 1 paper · 2013: 1 paper
Papers 3
- Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells. First author DOI 10.1007/s13238-013-0010-3↗
- Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells. First author DOI 10.4161/cbt.21412↗
- Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5. Co-author DOI 10.1038/aps.2011.130↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jun Zhou · 3 shared papers, 2011–2013 · strength 0.10
- Paper Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cance… DOI 10.1007/s13238-013-0010-3↗
- Paper Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells. DOI 10.4161/cbt.21412↗
- Paper Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of m… DOI 10.1038/aps.2011.130↗
- Min Liu · 3 shared papers, 2011–2013 · strength 0.10
- Paper Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cance… DOI 10.1007/s13238-013-0010-3↗
- Paper Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells. DOI 10.4161/cbt.21412↗
- Paper Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of m… DOI 10.1038/aps.2011.130↗
- Dengwen Li · 2 shared papers, 2012–2013 · strength 0.07
- Songbo Xie · 1 shared paper, 2013 · strength 0.04
- Chao Zhang · 1 shared paper, 2012 · strength 0.03
- Youguang Luo · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.